Central Glass (4044) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
21 Oct, 2026Executive summary
FY2024 net sales were ¥144.233bn, down 10.0% YoY, and operating profit fell 26.8% to ¥10.629bn; weaker electrolyte, medical-chemical and construction-glass sales and high glass input costs weighed on results.
FY2025 forecast: net sales ¥145.0bn, operating profit ¥7.5bn and profit attributable to owners ¥5.5bn; annual dividend planned at ¥170/share.
Financial highlights
FY2024 ordinary profit was ¥12.164bn, down 25.2% YoY; profit attributable to owners fell 54.5% to ¥5.678bn and comprehensive income declined 51.7% to ¥7.512bn.
Gross profit declined to ¥39.358bn from ¥42.356bn; basic EPS fell to ¥229.14 from ¥503.55.
Versus February forecast, net sales were ¥144.2bn vs ¥145.0bn, operating profit ¥10.6bn vs ¥10.5bn and net income ¥5.7bn vs ¥6.5bn; net income was affected by a partial deferred-tax-asset reversal.
Operating cash flow was ¥23.587bn, investing cash flow −¥4.244bn and financing cash flow −¥17.567bn; year-end cash and equivalents were ¥22.040bn.
Outlook and guidance
FY2025 forecast: net sales ¥145.0bn, operating profit ¥7.5bn, ordinary profit ¥8.0bn and profit attributable to owners ¥5.5bn.
FY2025 R&D forecast is ¥8.0bn; assumptions include ¥140/US$ exchange rate and $72.4/bbl CIF crude oil.
VISION 2030 targets operating profit of ¥20bn and ROE of at least 10%; FY2027 Phase 1 targets operating profit of ¥15bn and ROE of 8.7%.
Latest events from Central Glass
- New semiconductor materials support a ¥470億 FY2030 sales target.4044
Investor update - Higher H1 sales masked sharp profit declines, prompting lower FY2023 guidance.4044
Q2 2023 - Sales growth was offset by lower operating profit and net income.4044
Q1 2023 - FY2023 beat profit forecasts, but FY2024 earnings are expected to retreat.4044
Q4 2023 - Stronger glass sales could not offset lower chemical earnings and reduced extraordinary income.4044
Q3 2023 - Sales fell 10.7%, but operating profit rose on LCM support; FY guidance was unchanged.4044
Q1 2024 - Weak demand cut nine-month results and FY2024 forecasts; the ¥170 dividend was maintained.4044
Q3 2024 - H1 earnings fell on weaker demand and a share-sale loss; FY guidance was unchanged.4044
Q2 2024 - H1 operating profit fell 47.3% amid electrolyte pressure; FY2025 guidance was cut.4044
Q2 2025